KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes
- Bimarzhan Assatova
- , Robert Willim
- , Christopher Trevisani
- , Garrett Haskett
- , Khyati Maulik Kariya
- , Kusha Chopra
- , Sung Rye Park
- , Michael Yevgeniy Tolstorukov
- , Sean M. McCabe
- , Jessica Duffy
- , Abner Louissaint
- , Jani Huuhtanen
- , Dipabarna Bhattacharya
- , Satu Mustjoki
- , Min Jung Koh
- , Foster Powers
- , Elizabeth A. Morgan
- , Lei Yang
- , Brandy Pinckney
- , Matthew J. Cotton
- Massachusetts General Hospital Cancer Center
- Dana-Farber Cancer Institute
- Beth Israel Deaconess Medical Center
- Harvard University
- SUNY Upstate Medical University
- Massachusetts General Hospital
- University of Helsinki
- Georgetown University
- University of Minnesota Twin Cities
- Brigham and Women’s Hospital
- University of Texas Health Science Center at Houston
- Cleveland Clinic Foundation
- University of Toronto
- University of Nebraska Medical Center
- University of Virginia
- Northwestern University
- Ghent University
- Broad Institute
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Scopus
citations